课题基金 / 基金详情

What works for Whom in Pediatric OCD

What works for Whom in Pediatric OCD
什么对儿童强迫症患者有效
批准号:
10665713
负责人:
DAVID Heaton BARKER
金额:
$34.69万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2025-06-30

项目摘要

项目成果

DAVID Heaton BARKER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract Improving patient outcomes will be enhanced by understanding “what works, for whom?” enabling better matching of patients to available treatments. Despite a wealth of research seeking to optimize CBT outcomes for pediatric obsessive-compulsive disorder (OCD), we have limited understanding about how to match patients with the appropriate treatment package. Past research has identified patient characteristics that may influence treatment response, including age, symptom severity, comorbidities, and previous treatment history. Unfortunately, findings have been inconsistent due to limited sample size, a focus on one modifier at a time, and difficulty integrating results across trials with different sample characteristics. Between-trial differences in sample characteristics severely limit conventional meta-analytic tools, greatly complicating cross-trial comparisons of treatment efficacy. This project will use individual-participant-data from 27 trials and data from two clinical populations and utilize recent advancements in transportability methods facilitates understanding “what works, for whom?” Transportability methods include causal analytic approaches to extend inferences from trial samples to target populations when there are marked differences in the distribution of sample characteristics between trials and the target population. Robust statistical models are used to address between-trial differences in covariates, enabling the transportation of causal estimates from trial samples to target populations. Under explicit causal and statistical assumptions, the transported analyses provide unbiased estimates of how interventions will fair in the target population(s), enabling apples-to-apples comparisons of interventions even when two interventions have not been compared in a head-to-head trial. In addition, the target population can be defined as sub-populations (e.g., younger children with high illness severity, comorbidities), enabling evaluation of relevant interventions for that sub-population, effectively providing insight into the question of “what works for whom?”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sleep and Circadian Methods (SCM) Core
  • 批准号:
    10594995
  • 项目类别:
  • 资助金额:
    $48.51万
  • 财政年份:
    2021
  • 负责人:
    DAVID Heaton BARKER
  • 依托单位:
Sleep and Circadian Methods (SCM) Core
  • 批准号:
    10385697
  • 项目类别:
  • 资助金额:
    $48.99万
  • 财政年份:
    2021
  • 负责人:
    DAVID Heaton BARKER
  • 依托单位:
Sleep and Circadian Methods (SCM) Core
  • 批准号:
    10090149
  • 项目类别:
  • 资助金额:
    $31.47万
  • 财政年份:
    2021
  • 负责人:
    DAVID Heaton BARKER
  • 依托单位:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
  • 批准号:
    9026651
  • 项目类别:
  • 资助金额:
    $16.96万
  • 财政年份:
    2014
  • 负责人:
    DAVID Heaton BARKER
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: